For many applications, the Australian Pesticides and Veterinary Medicines Authority (APVMA) is required to publish a summary of the application once the applicant has been notified that the application has been accepted for assessment. The summary will be removed once the application is finalised.

The types of applications requiring an application summary include those for new active constituents, products and labels and applications involving variation to products and labels, where the variation involves a change in the use, supply or disposal of the product.

The summaries include details of the applications as specified in Divisions 2.1 and 2.2 of the regulations.

Please remember to follow the guidance for preparing information lists when preparing your application to avoid sensitive information being published.

For more information, please see the questions and answers.

Use the filter and links below to find and view application summaries.

Date

Application Date

Application No

Application Number

145211
Product/Active constituent Name

Application Product Name

Cropnosys Azoxystrobin 250 SC Fungicide

Application details

Product name:

Cropnosys Azoxystrobin 250 SC Fungicide

Product number:

95297

Applicant Name:

CROPNOSYS INDIA PRIVATE LIMITED

Application purpose and description of use:

Registration of a 250 g/L soluble concentrate formulation of azoxystrobin for the control of control of various diseases of Grapes, Potatoes, Tomatoes, Cucurbits, Avocados, Mangoes, Passionfruit and Poppies, as per the Directions for Use.

Reference details:

84248 - Raystar Azoxystrobin 250SC Fungicide

Active constituents:

Active constituent name
64896 - AZOXYSTROBIN
Date

Application Date

Application No

Application Number

145190
Product/Active constituent Name

Application Product Name

Cropnosys Diflufenican 500 SC Herbicide

Application details

Product name:

Cropnosys Diflufenican 500 SC Herbicide

Product number:

95287

Applicant Name:

CROPNOSYS INDIA PRIVATE LIMITED

Application purpose and description of use:

Registration of a 500 g/L suspension concentrate of diflufenican for the control of certain weeds in clover-based Pasture, Field Peas, Lentils, Lupins and Oilseed Poppy as specified in the Directions for Use table

Reference details:

85293 - Diflukey Herbicide

Active constituents:

Active constituent name
69078 - DIFLUFENICAN
Date

Application Date

Application No

Application Number

145189
Product/Active constituent Name

Application Product Name

Cropnosys Propaquizafop 100EC Herbicide

Application details

Product name:

Cropnosys Propaquizafop 100EC Herbicide

Product number:

95286

Applicant Name:

CROPNOSYS INDIA PRIVATE LIMITED

Application purpose and description of use:

Registration of a 100 g/L emulsifiable concentrate of propaquizafop for post-emergence selective weed control of annual grasses in broadleaf crops and legume pastures as specified in the Directions for Use table.

Reference details:

60764 - SHOGUN HERBICIDE

Active constituents:

Active constituent name
44365 - PROPAQUIZAFOP
Date

Application Date

Application No

Application Number

145183
Product/Active constituent Name

Application Product Name

PROPENTOFYLLINE

Application details

Product name:

PROPENTOFYLLINE

Active name:

PROPENTOFYLLINE

Applicant Name:

INTERVET AUSTRALIA PTY LIMITED

Application purpose and description of use:

Approval of Propentofylline source for use in veterinary chemical products

Description of data provided:

Data no
276906
Author
Anon
Title
Analytical test procedure AI site
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276907
Author
Anon
Title
Validation of Analytical Procedure AI Site Summary
Study date
December 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276908
Author
Anon
Title
Analytical method validation protocol & report for related substances by HPLC
Study date
8 September 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276909
Author
Anon
Title
Analytical method validation protocol & report for Assay by HPLC
Study date
19 August 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276910
Author
Anon
Title
Analytical method validation protocol & report determination residual solvents by GC-HS
Study date
21 October 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276911
Author
Anon
Title
Analytical method verification protocol & report of DSC method
Study date
22 October 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276912
Author
Anon
Title
Analytical method verification protocol & report of PSD method
Study date
24 October 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276913
Author
Anon
Title
Analytical method verification protocol & report for identification by FTIR
Study date
24 October 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276914
Author
Anon
Title
Batch Analyses & Results AI-Site
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276915
Author
Anon
Title
CoA J13910223_001
Study date
2 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276916
Author
Anon
Title
CoA J13910223_002
Study date
2 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276917
Author
Anon
Title
CoA J13910223_003
Study date
2 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276918
Author
Anon
Title
CoA J13910223_004
Study date
2 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276919
Author
Anon
Title
CoA J73910223_001
Study date
2 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276892
Author
MSD Animal Health
Title
CoA 0000707863 MSD
Study date
21 August 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276893
Author
MSD Animal Health
Title
CoA 0000728313 MSD
Study date
22 August 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276894
Author
MSD Animal Health
Title
CoA 0000728313 MSD
Study date
22 August 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276895
Author
MSD Animal Health
Title
CoA 0000732422 MSD New Site
Study date
9 November 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276896
Author
MSD Animal Health
Title
CoA 0000732420 MSD New Site
Study date
9 November 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276897
Author
MSD Animal Health
Title
CoA 0000732423 MSD New Site
Study date
9 November 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276889
Author
MSD Animal Health
Title
Comparison Batch analyses results
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276890
Author
Anon
Title
API Specification_Aug2019
Study date
August 2019
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276898
Author
Anon
Title
Hygroscopicity Report
Study date
26 May 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276899
Author
Anon
Title
Manufacturing process new AI site
Study date
December 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276900
Author
Anon
Title
Structural Elucidation Report (3 batches)
Study date
20 June 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276901
Author
Anon
Title
Impurities new AI site
Study date
April 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276902
Author
Anon
Title
Fate & Purge Report
Study date
29 September 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276903
Author
Anon
Title
Assessment and Control of DNA Reactive Genotoxic (Mutagenic) Impurities
Study date
30 March 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276904
Author
Anon
Title
Initial Risk Assessment Report
Study date
30 March 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276905
Author
Anon
Title
Standard specification new AI site
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276920
Author
Anon
Title
Justification of specification AI-site
Study date
December 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276891
Author
MSD Animal Health
Title
Expert Report
Study date
15 July 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276886
Author
Anon
Title
ASMFv4 Part 1_Aug2024
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276887
Author
Anon
Title
ASMFv4 Part 2_Aug2024
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276888
Author
MSD Animal Health
Title
Executive Summary
Study date
21 August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276921
Author
Anon
Title
Forced Degradation Study Protocol AI-site
Study date
25 November 2022
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276922
Author
Anon
Title
Forced Degradation Study Report AI-site
Study date
12 January 2023
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Data no
276923
Author
Anon
Title
Stability data AI-Site
Study date
August 2024
Authorising party
Applicant
Auth party contact address
91-105 Harpin Street BENDIGO EAST Australia
Date

Application Date

Application No

Application Number

144883
Product/Active constituent Name

Application Product Name

SWIFT POUR-ON FOR SHEEP

Application details

Product name:

SWIFT POUR-ON FOR SHEEP

Product number:

95184

Applicant Name:

NUTRIEN AG SOLUTIONS LIMITED

Application purpose and description of use:

Registration of a 4.0 mg/ml abamectin and 35.0 mg/ml imidacloprid liquid pour-on product for the treatment and control of susceptible strains of lice (Bovicola ovis) on sheep, including synthetic pyrethroid resistant lice, when applied up to 7 days after shearing.

Reference details:

85544 - FENNEC POUR-ON FOR SHEEP

Active constituents:

Active constituent name
83130 - Abamectin
Active constituent name
83018 - Imidacloprid

Description of data provided:

Data no
275790
Author
Anon
Title
Swift Pour-On for Sheep Specifications
Study date
21-Jun-2024
Authorising party
Applicant
Auth party contact address
Level 5, Building A, 26 Talavera Road MACQUARIE PARK Australia
Data no
281709
Author
Nutrien Ag Solutions Limited
Title
Updated product specifications
Study date
2024
Authorising party
Applicant
Auth party contact address
Level 5, Building A, 26 Talavera Road MACQUARIE PARK Australia
Data no
283295
Author
Nutrien Ag Solutions Limited
Title
Updated product specifications
Study date
13/02/2025
Authorising party
Applicant
Auth party contact address
Level 5, Building A, 26 Talavera Road MACQUARIE PARK Australia
Data no
281708
Author
Nutrien Ag Solutions Limited
Title
Response to Section 159(1)(a) notice for application 95184/144883, Swift Pour-On for Sheep
Study date
27-11-2024
Authorising party
Applicant
Auth party contact address
Level 5, Building A, 26 Talavera Road MACQUARIE PARK Australia
Date

Application Date

Application No

Application Number

145080
Product/Active constituent Name

Application Product Name

Chlorfenapyr

Application details

Product name:

Chlorfenapyr

Active name:

Chlorfenapyr

Applicant Name:

SHANDONG XINLONG GROUP BIOTECHNOLOGY CO LTD

Application purpose and description of use:

Approval of Chlorfenapyr technical grade material for use in agricultural chemical products.

Description of data provided:

Data no
276745
Author
Ling Fu
Title
Preliminary Analysis and Enforcement Analytical Method of CHLORFENAPYR TC ???Validation of Analytical Methodology for the Assay of Active Ingredient, Impurities and Subsequent 5-Batch Analysis of CHLORFENAPYR TC
Study date
14/09/2021
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Data no
276746
Author
Nutrichem laboratory Co., Ltd.
Title
Preliminary Analysis and Enforcement Analytical Method of CHLORFENAPYR TC ???Validation of Analytical Methodology for the Assay of Active Ingredient, Impurities and Subsequent 5-Batch Analysis of CHLORFENAPYR TC
Study date
05/2021
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Data no
276747
Author
Shandong Xinlong Group Biotechnology Co., Ltd.
Title
Declaration of composition - Chlorfenapyr TC
Study date
08/08/2024
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Data no
282845
Author
Nutrien
Title
Active and impurities identification
Study date
2021
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Data no
282846
Author
Nutrien
Title
Five-batch analysis data
Study date
2021
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Data no
276744
Author
Shandong Xinlong Group Biotechnology Co., Ltd.
Title
Manufacturing Process of Chlorfenapyr TC and Impurities Justification
Study date
13/12/2021
Authorising party
Applicant
Auth party contact address
No.26 Tianliu Section No.3 Road Tianliu Town Shouguang, Weifang China
Date

Application Date

Application No

Application Number

144731
Product/Active constituent Name

Application Product Name

AURAZOL MINIDOSE CATTLE DRENCH

Application details

Product name:

AURAZOL MINIDOSE CATTLE DRENCH

Product number:

95117

Applicant Name:

AURA LABORATORIES LIMITED

Application purpose and description of use:

Registration of a 112.5 g/L ALBENDAZOLE Oral Drench product is proposed for the control of benzimidazole-sensitive mature and immature gastrointestinal roundworms (including inhibited type II Ostertagia larvae), lungworms, tapeworms and to aid in the control of adult liver fluke in cattle. It also reduces the output of viable worm and fluke eggs and for hook drenching of beef and dairy cattle.

Reference details:

85538 - INDEPENDENTS OWN ALBEMAX MINI-DOSE CATTLE DRENCH

Description of data provided:

Data no
274371
Author
Anon
Title
Finished Product Specs
Study date
2024
Authorising party
Applicant
Auth party contact address
7 Puninga Lane Takanini Auckland New Zealand
Date

Application Date

Application No

Application Number

145186
Product/Active constituent Name

Application Product Name

eChem Promid 500 WG Herbicide

Application details

Product name:

eChem Promid 500 WG Herbicide

Product number:

95283

Applicant Name:

ECHEM (AUST) PTY LIMITED

Application purpose and description of use:

Registration of a 500 g/kg propyzamide water dispersible granule product for selective control of certain grasses and broadleaf weeds in lettuce, sports turf, home lawns and legume seed crops and pastures

Reference details:

88974 - Sabakem Propyzamide 500 WG Herbicide

Active constituents:

Active constituent name
80007 - PROPYZAMIDE
Date

Application Date

Application No

Application Number

145219
Product/Active constituent Name

Application Product Name

ILIUM TEMVET INJECTION

Application details

Product name:

ILIUM TEMVET INJECTION

Product number:

67612

Applicant Name:

TROY LABORATORIES PTY LTD

Application purpose and description of use:

Variation of registration to amend product formulation.

Active constituents:

Active constituent name
81514 - BUPRENORPHINE HYDROCHLORIDE
Active constituent name
81514 - BUPRENORPHINE HYDROCHLORIDE

Description of data provided:

Data no
277203
Author
Troy Laboratories
Title
Supporting information
Study date
2024
Authorising party
Applicant
Auth party contact address
37 GLENDENNING ROAD GLENDENNING Australia
Date

Application Date

Application No

Application Number

144732
Product/Active constituent Name

Application Product Name

Albendazole

Application details

Product name:

Albendazole

Active name:

Albendazole

Applicant Name:

AURA LABORATORIES LIMITED

Application purpose and description of use:

New source of pharmacopoeia active constituent.

Description of data provided:

Data no
276301
Author
Anon
Title
Active Certificates of analysis
Study date
2024
Authorising party
Applicant
Auth party contact address
7 Puninga Lane Takanini Auckland New Zealand
Data no
279807
Author
Registrant
Title
AURA - Albendazole API -Qquery response - Justification for residual solvent ' Mesityl oxide' limits in the COA
Study date
October 2024
Authorising party
Applicant
Auth party contact address
7 Puninga Lane Takanini Auckland New Zealand
Date

Application Date

Application No

Application Number

145160
Product/Active constituent Name

Application Product Name

F.S.A. 24DB Herbicide

Application details

Product name:

F.S.A. 24DB Herbicide

Product number:

87501

Applicant Name:

FOUR SEASONS AGRIBUSINESS PTY LTD

Application purpose and description of use:

Variation of product registration to update formulation.

Active constituents:

Active constituent name
68528 - 2,4-DB
Active constituent name
47083 - 2,4-DB

Description of data provided:

Data no
277183
Author
Emma Waller
Title
Consent For Use of Confidential Commercial Information
Study date
19 August 2024
Authorising party
Nufarm Australia Ltd
Data no
277184
Author
Emma Waller
Title
Formulation details for the above reference product
Study date
19 August 2024
Authorising party
Nufarm Australia Ltd
Auth party contact address
103-105 Pipe Road, Laverton North VIC 3026
Date

Application Date

Application No

Application Number

145204
Product/Active constituent Name

Application Product Name

BIMACURE CEPHAPIRIN BENZATHINE INTRA-UTERINE SUSPENSION FOR CATTLE

Application details

Product name:

BIMACURE CEPHAPIRIN BENZATHINE INTRA-UTERINE SUSPENSION FOR CATTLE

Product number:

94400

Applicant Name:

BIMEDA (AUSTRALIA) PTY. LIMITED

Application purpose and description of use:

Variation of product registration to vary relevant particulars.

Active constituents:

Active constituent name
94401 - cephapirin benzathine

Description of data provided:

Data no
277074
Author
Anon
Title
GMP
Study date
2022
Authorising party
Public
Auth party contact address
-
Date

Application Date

Application No

Application Number

145200
Product/Active constituent Name

Application Product Name

RAZOR EQUINE WORMER

Application details

Product name:

RAZOR EQUINE WORMER

Product number:

59467

Applicant Name:

VIRBAC (AUSTRALIA) PTY LTD

Application purpose and description of use:

Variation of product registration to extend the product shelf life

Active constituents:

Active constituent name
80904 - PRAZIQUANTEL
Active constituent name
56221 - PRAZIQUANTEL
Active constituent name
81934 - Praziquantel
Active constituent name
55643 - IVERMECTIN
Active constituent name
83261 - Praziquantel
Active constituent name
52892 - IVERMECTIN
Active constituent name
84516 - IVERMECTIN
Active constituent name
52892 - IVERMECTIN
Active constituent name
84516 - IVERMECTIN
Active constituent name
80904 - PRAZIQUANTEL

Description of data provided:

Data no
277023
Author
B Westcott
Title
Active RS 1
Study date
Dec 2022
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277020
Author
Virbac
Title
Executive summary
Study date
Aug 2024
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277026
Author
S Coulbourne
Title
Test method - preservatives
Study date
Jan 2012
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277021
Author
Virbac
Title
Final stability report
Study date
Jul 2024
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277024
Author
R Moulds
Title
Active RS 2
Study date
Sep 2019
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277022
Author
Anon
Title
CoAs
Study date
July 2024
Authorising party
Applicant
Auth party contact address
361 HORSLEY ROAD MILPERRA Australia
Data no
277025
Author
USP-NF
Title
Test methods - microbiology
Study date
Aug 2024
Authorising party
Public
Auth party contact address
-
Date

Application Date

Application No

Application Number

144890
Product/Active constituent Name

Application Product Name

Pregabalin

Application details

Product name:

Pregabalin

Product number:

95189

Applicant Name:

MAVLAB ANIMAL HEALTH PTY LTD

Application purpose and description of use:

Registration of a 50 mg/mL pregabalin oral solution product for the alleviation of acute anxiety and fear in cats associated with transportation and veterinary visits, in conjunction with approval of pregabalin.

Description of data provided:

Data no
276765
Author
Not identified
Title
ASMF (Restricted) 3.2.S.2.2 Description of manufacturing procedures
Study date
August 2023
Authorising party
Manufacturer
Data no
276766
Author
Not identified
Title
ASMF (Restricted) 3.2.S.2.3 Control of Materials
Study date
2023
Authorising party
Manufacturer
Data no
276767
Author
Not identified
Title
ASMF (Restricted) 3.2.S.2.4 Controls of Critical Steps and Intermediates
Study date
2023
Authorising party
Manufacturer
Data no
276768
Author
Not identified
Title
ASMF (Restricted) 3.2.S.2.5 Process Validation and/or Evaluation
Study date
2023
Authorising party
Manufacturer; Manufacturer
Auth party contact address
;
Data no
276769
Author
Not identified
Title
ASMF (Restricted) 3.2.S.2.6 Manufacturing Process Development
Study date
2019
Authorising party
Manufacturer
Date

Application Date

Application No

Application Number

144891
Product/Active constituent Name

Application Product Name

Bonqat 50 mg/mL Oral Solution for Cats

Application details

Product name:

Bonqat 50 mg/mL Oral Solution for Cats

Product number:

95190

Applicant Name:

MAVLAB ANIMAL HEALTH PTY LTD

Application purpose and description of use:

Registration of a 50 mg/mL pregabalin oral solution product for the alleviation of acute anxiety and fear in cats associated with transportation and veterinary visits, in conjunction with approval of pregabalin.

Description of data provided:

Data no
276116
Author
Anon
Title
ASMF (Open) 3.2.S.4.2 Analytical procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276117
Author
Anon
Title
ASMF (Open) 3.2.S.4.3 Validation of analytical procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276118
Author
Anon
Title
ASMF (Open) 3.2.S.4.4 Batch analyses
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275832
Author
Not identified
Title
Active constituent CoAs
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275833
Author
EDQM
Title
pregabalin-cep
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276119
Author
Anon
Title
ASMF (Open) 3.2.S.4.5 Justification of specifications
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276111
Author
Anon
Title
ASMF (Open) 3.2.S.2.1 Manufacturers
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276112
Author
Anon
Title
ASMF (Open) 3.2.S.2.2 Description of manufacturing procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276115
Author
Anon
Title
ASMF (Open) 3.2.S.4.1 Specification
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276057
Author
Anon
Title
3.2.S.4.1 Specification
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276047
Author
Anon
Title
QOS-2-3-s-drug-substance
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276113
Author
Anon
Title
ASMF (Open) 3.2.S.3.1 Elucidation of structure
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276114
Author
Anon
Title
ASMF (Open) 3.2.S.3.2 Impurities
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276108
Author
Anon
Title
ASMF (Open) 3.2.S.1.1 Nomenclature
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276109
Author
Anon
Title
ASMF (Open) 3.2.S.1.2 Structure
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276110
Author
Anon
Title
ASMF (Open) 3.2.S.1.3 General properties
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276120
Author
Anon
Title
ASMF (Open) 3.2.S.5 Reference standards
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276121
Author
Anon
Title
ASMF (Open) 3.2.S.6 Container closure system
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276122
Author
Anon
Title
ASMF (Open) 3.2.S.7.1 Stability summary
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276123
Author
Anon
Title
ASMF (Open) 3.2.S.7.2 Post-approval stability
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276124
Author
Anon
Title
ASMF (Open) 3.2.S.7.3 Stability data
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276086
Author
Anon
Title
3.2.P.5.2 Analytical Procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276087
Author
Anon
Title
M122238 Deliverable volume
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276088
Author
Anon
Title
M122961 Clarity colour NZ AU
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276089
Author
Anon
Title
M123145 Sodium Benzoate
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276090
Author
Anon
Title
M123146 UHPLC NZ AU
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276091
Author
Anon
Title
USP-NF 698
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276092
Author
Anon
Title
3.2.P.5.3 Validation of Analytical Procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276093
Author
Anon
Title
Suitability study micro impurities
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276094
Author
Anon
Title
Validation report UHPLC method
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276095
Author
Anon
Title
Validation report-Sodium benzoate assay
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276063
Author
Anon
Title
3.2.P.4.2 Analytical Procedures
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276064
Author
Anon
Title
M122848 ID by IR
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276065
Author
Anon
Title
M122850 Residue on Ignition
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276066
Author
Anon
Title
M122851 Water
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276067
Author
Anon
Title
M123930 ID assay organic impurities
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276068
Author
Anon
Title
USP-NF 197 Spectro ID Tests
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276069
Author
Anon
Title
USP-NF 921 Water determination
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275841
Author
Anon
Title
Response to D120 LoQ: Appendix 15-2
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276085
Author
Anon
Title
3.2.P.5.4 Batch Analyses
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276049
Author
Anon
Title
3.2.P.2.1 Descr and Composition-Drug Product
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276050
Author
Anon
Title
3.2.P.3.2 Batch Formula
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276051
Author
Anon
Title
3.2.P.2.1 Components of Drug Product
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276052
Author
Anon
Title
3.2.P.2.2 Drug Product
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276058
Author
Anon
Title
3.2.P.4.1 Specifications_2
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276059
Author
Anon
Title
3.2.P.4.3 Validation Analyt Proc
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276060
Author
Anon
Title
3.2.P.4.4 Justification Specifications
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276054
Author
Anon
Title
3.2.P.2.4 Container Closure System
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276055
Author
Anon
Title
3.2.P.2.5 Microbiol Attributes
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276056
Author
Anon
Title
3.2.P.2.6 Compatibility
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276082
Author
Anon
Title
3.2.P.5.1 Specifications EU
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276083
Author
Anon
Title
3.2.P.5.5 Characterisation Impurities
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276084
Author
Anon
Title
3.2.P.5.6 Justification Specifications
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276070
Author
Anon
Title
3.2.P.3.1 Manufacturers 4
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276071
Author
Anon
Title
3.2.P 3.3 Description Manufacturing Process and Controls EU
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276072
Author
Anon
Title
3.2.P.3.5 Process Validation and or Evaluation
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276073
Author
Anon
Title
3.2.P.3.4 Controls Critical Steps and Intermediates
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275885
Author
Anon
Title
CVMP additional response
Study date
2022
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275836
Author
Anon
Title
Response to D120 LoQ: Appendix 1-1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275837
Author
Anon
Title
Response to D120 LoQ: Appendix 1b.1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275838
Author
Anon
Title
Response to D120 LoQ: Appendix 13-1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275839
Author
Anon
Title
Response to D120 LoQ: Appendix 13-2
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275840
Author
Anon
Title
Response to D120 LoQ: Appendix 15-1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275870
Author
Anon
Title
Response to D180 LoOI: Appendix 4-1
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276074
Author
Anon
Title
3.2.P.7 Container Closure System
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276075
Author
Anon
Title
Compliance cert-child resistant closure
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276076
Author
Anon
Title
Compliance cert-closure with adapter
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276077
Author
Anon
Title
Compliance cert-glass bottle
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276078
Author
Anon
Title
Compliance cert-measuring device
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276079
Author
Anon
Title
Drawing-typeIII glass bottle 5ml
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276080
Author
Anon
Title
Tech drawing-measuring device
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276061
Author
Anon
Title
3.2.P.4.5 Excipients of Human or Animal Origin
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276062
Author
Anon
Title
3.2.P.4.6 Novel Excipients
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276053
Author
Anon
Title
3.2.P.2.3 Manuf Process Devt EU
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276048
Author
Anon
Title
QOS-2-3-r-regional-information
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276045
Author
Anon
Title
Quality Overall Summary - introduction
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276046
Author
Anon
Title
QOS-2-3-p-drug-product
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276096
Author
Anon
Title
3.2.P.8.1 Stability Summary and Conclusions AU NZ
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276097
Author
Anon
Title
3.2.P.8.2 Post-approval stability commitment CH
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276098
Author
Anon
Title
3.2.P.8.3 Stability data
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276099
Author
Anon
Title
Results primary stability BN 1901424
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276100
Author
Anon
Title
Results primary stability BN 1901426
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276101
Author
Anon
Title
Results primary stability BN 1903372
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276102
Author
Anon
Title
Results-freeze thaw study
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276103
Author
Anon
Title
Results-photostability
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276104
Author
Anon
Title
Results - in-use stability
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276105
Author
Anon
Title
Results-in-use stability end shelf life
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276107
Author
Anon
Title
Stability ST excursions
Study date
2022
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276005
Author
Burns K
Title
Vital statistics
Study date
2013
Authorising party
Public
Auth party contact address
-
Data no
276029
Author
Field MJ et al
Title
Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity
Study date
2001
Authorising party
Public
Auth party contact address
-
Data no
276036
Author
Anon
Title
Summary of Product Characteristics
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
276043
Author
Wang Z et al
Title
Anxiolytic-like effect of pregabalin on unconditioned fear in the rat: An autoradiographic brain perfusion mapping and functional connectivity study
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
276044
Author
Zohar J et al
Title
Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275965
Author
Anon
Title
Efficacy Report No. V3120001
Study date
2017
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275966
Author
Anon
Title
Efficacy Report No. V3120002
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275967
Author
Anon
Title
Pharmacology Report No. 510825
Study date
2016
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275962
Author
Anon
Title
Cat owner survey report
Study date
2017
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276008
Author
Hammerle M et al
Title
2015 AAHA Canine and Feline Behavior Management Guidelines
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
276009
Author
Mariti C et al
Title
Guardians' Perceptions of Cats' Welfare and Behavior Regarding Visiting Veterinary Clinics
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
276010
Author
Mariti C et al
Title
The perception of cat stress by Italian owners
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
276011
Author
Mills DS et al
Title
A triple blind placebo-controlled investigation into the assessment of the effect of Dog Appeasing Pheromone (DAP) on anxiety related behaviour of problem dogs in the veterinary clinic
Study date
2006
Authorising party
Public
Auth party contact address
-
Data no
276012
Author
Nibblett BM et al
Title
Comparison of stress exhibited by cats examined in a clinicversus a home setting
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
276013
Author
Quimby JM et al
Title
Evaluation of the effects of hospital visit stress on physiologic parameters in the cat
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
276014
Author
Anon
Title
Take your cat to the vet day
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
276015
Author
Stevens BJ et al
Title
Efficacy of a single dose of trazodone hydrochloride given to cats prior to veterinary visits to reduce signs of transport- and examination-related anxiety
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
276016
Author
van Haaften KA et al
Title
Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
276017
Author
Volk JO et al
Title
Executive summary of the Bayer veterinary care usage study
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
276018
Author
Arikkath J and Campbell KP
Title
Auxiliary subunits: essential components of the voltage-gated calcium channel complex
Study date
2003
Authorising party
Public
Auth party contact address
-
Data no
275842
Author
Anon
Title
Response to D120 LoQ: Appendix 41-1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275843
Author
Anon
Title
Response to D120 LoQ: Appendix 42-1
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275844
Author
Anon
Title
Response to D120 LoQ: Appendix 42-2
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275856
Author
Kendall K and Ley J
Title
Owner observations can provide data for constructive behavior analysis in normal pet cats in Australia
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275952
Author
Anon
Title
Development of resistance
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275886
Author
Anon
Title
Detailed and Critical Summary on Safety
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275887
Author
Anon
Title
Expert CV
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275888
Author
Andrade C
Title
Safety of Pregabalin in Pregnancy
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275889
Author
Anon
Title
Detailed and Critical Summary on Efficacy
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275890
Author
Anon
Title
Expert CV
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275891
Author
Anon
Title
Tabular formats
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275892
Author
Alger JM and Alger SF
Title
Cat Culture, Human Culture: An Ethnographic Study of a Cat Shelter
Study date
1999
Authorising party
Public
Auth party contact address
-
Data no
275893
Author
Archer J
Title
Why Do People Love Their Pets
Study date
1997
Authorising party
Public
Auth party contact address
-
Data no
275894
Author
Ballantyne KC
Title
Separation, Confinement, or Noises: What Is Scaring That Dog?
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275895
Author
Bear MF et al
Title
hapter 15 Chemical control of the brain and behaviour: The diffuse modulatory systems of the brain. In Neuroscience: Exploring the Brain.
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
275896
Author
Beata C et al
Title
Effects of alpha-casozepine (Zylkene) versus selegiline hydrochloride (Selfian, Anipryl) on anxiety disorders in dogs
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
275897
Author
Beck A and Katcher A
Title
Future Directions in Human-Animal Bond Research
Study date
2003
Authorising party
Public
Auth party contact address
-
Data no
275898
Author
Beerda B et al
Title
Manifestations of chronic and acute stress in dogs
Study date
1997
Authorising party
Public
Auth party contact address
-
Data no
275899
Author
Beerda B et al
Title
Behavioural, saliva cortisol and heart rate responses to different types of stimuli in dogs
Study date
1998
Authorising party
Public
Auth party contact address
-
Data no
275900
Author
Beetz A et al
Title
Psychosocial and psychophysiological effects of human-animal interactions: the possible role of oxytocin.
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275901
Author
Boothe DM
Title
Chapter 26 Drugs that modify animal behaviour. In Small Animal Clinical Pharmacology and Therapeutics.
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
275902
Author
Bowen J and Heath S
Title
Chapter 6 The role of pharmacology in behavioural medicine. In Behaviour Problems in Small Animals: Practical Advice for the Veterinary Team.
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
275903
Author
Chea B and Giorgi M
Title
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275904
Author
Conzemius MG and Evans RB
Title
Caregiver placebo effect for dogs with lameness from osteoarthritis.
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275905
Author
Crociolli GC et al
Title
Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275906
Author
Crowell-Davis S
Title
Benzodiazepines: pros and cons for fear and anxiety
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275907
Author
Crowell-Davis SL et al
Title
Chapter 6 Introduction to clinical psychopharmacology for veterinary medicine, Chapter 7 Benzodiazepines, Chapter 10 Anticonvulsants and mood stabilizers. In Veterinary Psychopharmacology.
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275908
Author
Deliconstantinos G
Title
Cortisol effect on (Na++K+)-stimulated ATPase activity and on bilayer fluidity of dog brain synaptosomal plasma membranes.
Study date
1985
Authorising party
Public
Auth party contact address
-
Data no
275909
Author
Dodman NH and Shuster L
Title
Chapter 5 Pharmacologic treatment of fear and anxiety in animals. In Psychopharmacology of animal behavior disorders.
Study date
1998
Authorising party
Public
Auth party contact address
-
Data no
275910
Author
Elzinga BM and Roelofs K
Title
Cortisol-Induced Impairments of Working Memory Require Acute Sympathetic Activation
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
275911
Author
Feighner JP
Title
Pharmacology: new antidepressants
Study date
1980
Authorising party
Public
Auth party contact address
-
Data no
275912
Author
Fine AH and Beck AM
Title
Chapter 1 Understanding Our Kinship with Animals: Input for Health Care Professionals Interested in the Human-Animal Bond. In: Handbook on Animal-Assisted Therap. 4th Edition
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275913
Author
Fine A
Title
Chapter 9 Animals and therapists: Incorporating animals in outpatient psychotherapy. In handbook on animal assisted therapy: Theoretical foundations and guidelines for practice.
Study date
2000
Authorising party
Public
Auth party contact address
-
Data no
275914
Author
Friedmann E and Son H
Title
The human-companion animal bond: how humans benefit
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
275915
Author
Gruen ME and Sherman BL
Title
Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275916
Author
Guedes AGP et al
Title
Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275917
Author
Hatch A
Title
The view from All Fours: A Look at an Animal-Assisted Activity Program from the Animal's Perspective
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
275918
Author
Hekman J et al
Title
Psychogenic Stress in Hospitalized Dogs: Cross Species Comparisons, Implications for Health Care, and the Challenges of Evaluation
Study date
2014
Authorising party
Public
Auth party contact address
-
Data no
275919
Author
Hudec CP and Griffin CE
Title
Changes in the stress markers cortisol and glucose before and during intradermal testing in cats after single administration of pre-appointment gabapentin
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275920
Author
Kendal K and Ley J
Title
Owner observations can provide data for constructive behavior analysis in normal pet cats in Australia
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275921
Author
Korpivaara M et al
Title
Dexmedetomidine oromucosal gel for noise-associated acute anxiety and fear in dogs - a randomised, double-blind, placebo-controlled clinical study.
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275922
Author
Landsberg G et al
Title
Chapter 8 Pharmacologic intervention in behavioural therapy. In Behavior Problems of the Dog and Cat 3rd edition
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
275923
Author
Lloyd JK
Title
Minimising stress for patients in the veterinary hospital: Why it is important and what can be done about it
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275924
Author
Manning A and Serpell J
Title
Chapter 1 From trust to domination. In Animals and human society: Changing perspectives.
Study date
1994
Authorising party
Public
Auth party contact address
-
Data no
275925
Author
Mariti C et al
Title
Guardians perceptions of cats welfare and behavior regarding visiting veterinary clinics.
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275926
Author
Mertens C
Title
Human-cat interactions in the home setting
Study date
1991
Authorising party
Public
Auth party contact address
-
Data no
275927
Author
Murana KR et al
Title
Placebo effect in canine epilepsy trials
Study date
2010
Authorising party
Public
Auth party contact address
-
Data no
275928
Author
Odendaal JSJ
Title
Science-based assessment of animal welfare: companion animals
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
275929
Author
Odendaal J and Lehmann S
Title
The role of phenylethylamine during positive human-dog interaction
Study date
2000
Authorising party
Public
Auth party contact address
-
Data no
275930
Author
Ogata N and Dodman N
Title
The use of clonidine in the treatment of fear-based behavior problems in dogs: an open trial
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
275931
Author
Orlando JM et al
Title
Use of oral trazodone for sedation in cats: a pilot study
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275933
Author
Pankratz KE et al
Title
Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275934
Author
Plumb DC
Title
Diazepam, Gabapentin. In Plumb's Veterinary Drug Handbook 8th edition
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275935
Author
Riviere JE and Papich MG
Title
Benzodiazepine derivatives. In Veterinary Pharmacology and Therapeutics
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275936
Author
Rooney NJ et al
Title
Behavioural and glucocorticoid responses of dogs (Canis familiaris) to kennelling: investigating mitigation of stress by prior habituation
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
275937
Author
Sales G et al
Title
Noise in dog kennelling: is barking a welfare problem for dogs?
Study date
1997
Authorising party
Public
Auth party contact address
-
Data no
275938
Author
Schatzberg AF and Nemeroff CB
Title
Chapter 38 Treatment of anxiety disorders. In Essentials of Clinical Psychopharmacology 3rd edition.
Study date
2013
Authorising party
Public
Auth party contact address
-
Data no
275939
Author
Sinn L
Title
Advances in Behavioral Psychopharmacology
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275940
Author
Steimer T
Title
The biology of fear-and anxiety-related behaviors
Study date
2002
Authorising party
Public
Auth party contact address
-
Data no
275941
Author
Stockham SL et al
Title
Clinical assessment of leukocytosis: distinguishing leukocytosis caused by inflammatory, glucocorticoid, physiology, and leukemic disorders or conditions
Study date
2003
Authorising party
Public
Auth party contact address
-
Data no
275942
Author
Timmins RP et al
Title
Enhancing quality of life for dogs and cats in confined situations
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
275943
Author
Uemura EE
Title
Chapter 21 Hypothalamus. In Fundamentals of Canine Neuroanatomy and Neurophysiology
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275944
Author
Walsh F
Title
Human-animal bonds I: The relational significance of companion animals
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
275961
Author
Anon
Title
Pharmacology Report No. 15253
Study date
2016
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275871
Author
Anon
Title
Response to D180 LoOI: Appendix 9-1
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275872
Author
Anon
Title
Response to D180 LoOI: Appendix 9-2
Study date
2015
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275873
Author
Anon
Title
Response to D180 LoOI: Appendix 9-3
Study date
2015
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275951
Author
Anon
Title
Pharmacology
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275969
Author
Anon
Title
Pharmacology Report No. 20139322
Study date
2018
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275970
Author
Anon
Title
Pharmacology Report No. 20184090
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275971
Author
Anon
Title
Pharmacology Report No. 20184153
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275972
Author
Anon
Title
Pharmacology Report No. 100018458
Study date
2015
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275973
Author
Anon
Title
Pharmacology Report No. AB20500
Study date
2014
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275974
Author
Anon
Title
Pharmacology Report No. AB20716
Study date
2015
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275980
Author
Corrigan BW et al
Title
An analysis of exposure response data for pregabalin: A novel therapy for the treatment of diabetic neuropathic pain
Study date
2001
Authorising party
Public
Auth party contact address
-
Data no
276019
Author
Aupperle RL et al
Title
Pregabalin Influences Insula and Amygdala Activation During Anticipation of Emotional Images
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
276020
Author
Bayer K et al
Title
Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels
Study date
2004
Authorising party
Public
Auth party contact address
-
Data no
276021
Author
Bian F et al
Title
Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: An ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice
Study date
2006
Authorising party
Public
Auth party contact address
-
Data no
276022
Author
Calandre EP et al
Title
Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
276023
Author
Coderre TJ et al
Title
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
276024
Author
Cole RL et al
Title
Differential Distribution of Voltage-Gated Calcium Channel Alpha-2 Delta (a2g) Subunit mRNA-Containing Cells in the Rat Central Nervous System and the Dorsal Root Ganglia
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
276025
Author
Dolphin AC
Title
Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
276026
Author
Dooley DJ et al
Title
Stimulus-Dependent Modulation of [3H]Norepinephrine Release from Rat Neocortical Slices by Gabapentin and Pregabalin
Study date
2000
Authorising party
Public
Auth party contact address
-
Data no
276027
Author
Dooley DJ et al
Title
Preferential Action of Gabapentin and Pregabalin at P/Q-Type Voltage-Sensitive Calcium Channels: Inhibition of K+-Evoked [3H]-Norepinephrine Release From Rat Neocortical Slices
Study date
2002
Authorising party
Public
Auth party contact address
-
Data no
276028
Author
Fehrenbache JC et al
Title
Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C
Study date
2003
Authorising party
Public
Auth party contact address
-
Data no
275963
Author
Anon
Title
Pharmacology Report No. r19027
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275964
Author
Anon
Title
Pharmacology Report No. r150331
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275991
Author
Anon
Title
Prescribing information
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275999
Author
Salazar V et al
Title
Pharmacokinetics of single-dose oral pregabalin administration in normal dogs
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
276004
Author
Bradshaw J and Thorne C
Title
Feeding Behaviour. In The Waltham Book of Dog and Cat Behaviour
Study date
1992
Authorising party
Public
Auth party contact address
-
Data no
276007
Author
Esteban MA et al
Title
Pharmacokinetics of Single-Dose Oral Pregabalin Administration in Normal Cats
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
276037
Author
Maneuf YP and McKnight AT
Title
Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase
Study date
2001
Authorising party
Public
Auth party contact address
-
Data no
276038
Author
Maneuf YP et al
Title
Gabapentin inhibits the substance P-facilitated K1-evoked release of [3H]glutamate from rat caudal trigeminal nucleus slices
Study date
2001
Authorising party
Public
Auth party contact address
-
Data no
276039
Author
Meder WP and Dooley DJ
Title
Modulation of K+-induced synaptosomal calcium influx by gabapentin
Study date
2000
Authorising party
Public
Auth party contact address
-
Data no
276040
Author
Mico JA and Preito R
Title
Elucidating the Mechanism of Action of Pregabalin
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
276041
Author
Nicolas LB et al
Title
Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
276042
Author
Taylor CP et al
Title
Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
Study date
1993
Authorising party
Public
Auth party contact address
-
Data no
276030
Author
Fink K et al
Title
Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices
Study date
2000
Authorising party
Public
Auth party contact address
-
Data no
276031
Author
Fink K et al
Title
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Study date
2002
Authorising party
Public
Auth party contact address
-
Data no
276032
Author
Frampton JE
Title
Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder
Study date
2014
Authorising party
Public
Auth party contact address
-
Data no
276033
Author
Li Z et al
Title
Pregabalin is a potent and selective ligand for a2g-1 and a2g-2 calcium channel subunits
Study date
2014
Authorising party
Public
Auth party contact address
-
Data no
276034
Author
Lotarski SM et al
Title
Anxiolytic-Like Activity of Pregabalin in the Vogel Conflict Test in a2g-1 (R217A) and a2g-2 (R279A) Mouse Mutants
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
276035
Author
Anon
Title
Product monograph
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
276002
Author
Vartanian MG et al
Title
Activity profile of pregabalin in rodent models of epilepsy and ataxia
Study date
2006
Authorising party
Public
Auth party contact address
-
Data no
276006
Author
Clark L et al
Title
Skin lesions following pregabalin administration in a cat
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275968
Author
Anon
Title
Pharmacology Report No. 518193
Study date
2017
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
276106
Author
Anon
Title
Safety Report No. 20305603
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275953
Author
Anon
Title
Tolerance in target animal species
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275954
Author
Anon
Title
Clinical
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275857
Author
Kien NT et al
Title
Preemptive analgesia after lumbar spine surgery by pregabalin and celecoxib: a prospective study
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275858
Author
Korff CP and Wiliamson BG
Title
Clinical Presentation of Chiari-like Malformation in 2 Persian Cats
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275859
Author
Montgomery SA
Title
Pregabalin for the treatment of generalised anxiety disorder
Study date
2006
Authorising party
Public
Auth party contact address
-
Data no
275860
Author
Montgomery S et al
Title
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability
Study date
2013
Authorising party
Public
Auth party contact address
-
Data no
275861
Author
Myhre M et al
Title
Pregabalin Has Analgesic, Ventilatory, and Cognitive Effects in Combination with Remifentanil
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275862
Author
Owen RT
Title
Pregabalin: Its Efficacy, Safety and Tolerability Profile in Generalized Anxiety
Study date
2007
Authorising party
Public
Auth party contact address
-
Data no
275863
Author
Savelloni J et al
Title
Risk of respiratory depression with opioids and concomitant gabapentinoids
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275864
Author
Slee A et al
Title
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275865
Author
Fagerhol V et al
Title
Pregabalin alleviates clinical signs of syringomyeliarelated central neuropathic pain in Cavalier King Charles Spaniel dogs: a randomized controlled trial
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275866
Author
Torres-Gonzalez MI et al
Title
Preoperative oral pregabalin for anxiety control: a systematic review
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275867
Author
Toth C
Title
Drug safety evaluation of pregabalin
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275868
Author
Zacny JP et al
Title
Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275845
Author
Bach DR et al
Title
Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275846
Author
Barrett J et al
Title
Multi-trial Analysis of the Duration and Intensity of Adverse Effects Associated with Pregabalin Adjunctive Treatment of Partial Seizures
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
275847
Author
Bonnet U and Scherbaum N
Title
How addictive are gabapentin and pregabalin? A systematic review
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275848
Author
Chen X et al
Title
Pharmacodynamic response profiles of anxiolytic and sedative drugs
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275849
Author
Djani DM and Draper WE
Title
Suspected phenobarbital-induced fever in a cat
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275850
Author
Eipe N and Penning J
Title
Postoperative respiratory depression associated with pregabalin: A case series and a preoperative decision algorithm
Study date
2011
Authorising party
Public
Auth party contact address
-
Data no
275851
Author
Feltner D et al
Title
Long-term efficacy of pregabalin in generalized anxiety disorder
Study date
2008
Authorising party
Public
Auth party contact address
-
Data no
275852
Author
Goich M et al
Title
Multimodal analgesia for treatment of allodynia and hyperalgesia after major trauma in a cat
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275853
Author
Gomes T et al
Title
Pregabalin and the Risk for Opioid-Related Death: A Nested Case?Control Study
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275854
Author
Griffin FC et al
Title
Evaluation of clinical examination location on stress in cats: a randomized crossover trial
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275855
Author
Isoardi KZ et al
Title
Pregabalin poisoning and rising recreational use: a retrospective observational series
Study date
2020
Authorising party
Public
Auth party contact address
-
Data no
275950
Author
Anon
Title
Environmental risk assessment
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275830
Author
Not identified
Title
Bonqat_Internat Doc Summary - FINAL
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275831
Author
EUDRA
Title
GMP certificates
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275869
Author
Anon
Title
bonqat-responses-to-looi
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275834
Author
Not identified
Title
Bonqat - Cross-Reference Table - FINAL
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275835
Author
Anon
Title
bonqat-responses-to-loq
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275821
Author
APVMA
Title
Project Plan - 141933
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275822
Author
APVMA
Title
PAA written assistance - 141933
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
277051
Author
Not identified
Title
EU Dossier
Study date
2024
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275823
Author
EMA
Title
Bonqat - D120 SO and LoQ
Study date
2020
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275824
Author
EMA
Title
Bonqat - D180 SO and LoOI
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275825
Author
EMA
Title
Bonqat Initial MA CVMP Assessment Report
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275826
Author
EMA
Title
Bonqat II-0002-G - AR
Study date
2022
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275827
Author
EMA
Title
VRA 004 Assessment Report
Study date
2022
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275828
Author
EMA
Title
VRA 005 Assessment Report
Study date
2023
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275829
Author
Not identified
Title
SPC ema-bonqat-50-mg-ml-200223-en
Study date
2023
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275955
Author
Anon
Title
Toxicology Report No. 784106
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275960
Author
Anon
Title
Toxicology Report No. 20183660
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275995
Author
Moshiri M et al
Title
Injury to skeletal muscle of mice following acute and sub-acute pregabalin exposure
Study date
2017
Authorising party
Public
Auth party contact address
-
Data no
275959
Author
Anon
Title
Toxicology Report No. 20183658
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275958
Author
Anon
Title
Toxicology Report No. 20183657
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275981
Author
Criswell KA et al
Title
Pregabalin Induces Hepatic Hypoxia and Increases Endothelial Cell Proliferation in Mice, a Process Inhibited by Dietary Vitamin E Supplementation
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275982
Author
Criswell KA et al
Title
Mode of Action Associated With Development of Hemangiosarcoma in Mice Given Pregabalin and Assessment of Human Relevance
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275983
Author
Criswell KA et al
Title
Key Components of the Mode of Action for Hemangiosarcoma Induction in Pregabalin-Treated Mice: Evidence of Increased Bicarbonate, Dysregulated Erythropoiesis, Macrophage Activation, and Increased Angiogenic Growth Factors in Mice but Not in Rats
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275997
Author
Pegg D et al
Title
Hemangiosarcoma in Mice Administered Pregabalin: Analysis of Genotoxicity, Tumor Incidence, and Tumor Genetics
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275993
Author
Morse DC
Title
Embryo-Fetal Developmental Toxicity Studies with Pregabalin in Mice and Rabbits
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275994
Author
Morse DC et al
Title
Developmental Toxicity Studies with Pregabalin in Rats: Significance of Alterations in Skull Bone Morphology
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275956
Author
Anon
Title
Toxicology Report No. 8406560
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275957
Author
Anon
Title
Toxicology Report No. 8406561
Study date
2019
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275984
Author
Anon
Title
Consideration of ethyl maltol and two 6-keto-1,4-dioxane derivatives substances evaluated by JECFA (65th meeting)
Study date
2010
Authorising party
Public
Auth party contact address
-
Data no
275985
Author
Anon
Title
Scientific Opinion on the re-evaluation of benzoic acid (E 210), sodium benzoate (E 211), potassium benzoate (E 212) and calcium benzoate (E 213) as food additives
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275986
Author
Eskandarian T et al
Title
Efficacy and safety of premedication with single dose of oral pregabalin in children with dental anxiety: A randomized double-blind placebo-controlled crossover clinical trial
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
275987
Author
Anon
Title
Toxicological evaluation of some extraction solvents and certain other substances
Study date
1970
Authorising party
Public
Auth party contact address
-
Data no
275988
Author
Gralla EJ et al
Title
Toxicity studies with ethyl maltol
Study date
1969
Authorising party
Public
Auth party contact address
-
Data no
275989
Author
Hetta DF et al
Title
Analgesic efficacy of pregabalin in acute postmastectomy pain: placebo controlled dose ranging study
Study date
2016
Authorising party
Public
Auth party contact address
-
Data no
275975
Author
Anon
Title
021446_3a5 References
Study date
2004
Authorising party
Public
Auth party contact address
-
Data no
275976
Author
Bockbrader N et al
Title
Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers
Study date
2010
Authorising party
Public
Auth party contact address
-
Data no
275945
Author
Anon
Title
Precise identification of the product and its active substance(s)
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275946
Author
Anon
Title
Pharmacology
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275947
Author
Anon
Title
Toxicology
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275948
Author
Anon
Title
Other requirements
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275949
Author
Anon
Title
User risk assessment
Study date
2021
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275996
Author
Owen SC
Title
Handbook of Pharmaceutical Excipients 5th Edition
Study date
2005
Authorising party
Public
Auth party contact address
-
Data no
276003
Author
White PF et al
Title
The Effect of Pregabalin on Preoperative Anxiety and Sedation Levels: A Dose-Ranging Study
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
279817
Author
TGA
Title
Nonclinical Evaluation Report 1
Study date
2004
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
279818
Author
TGA
Title
Nonclinical Evaluation Report 2
Study date
2006
Authorising party
Applicant
Auth party contact address
29-33 ROWLAND STREET SLACKS CREEK Australia
Data no
275998
Author
Pognan F et al
Title
Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
276000
Author
Sikka SC et al
Title
Pregabalin Does Not Affect Sperm Production in Healthy Volunteers: A Randomized, Double-blind, Placebo-controlled, Noninferiority Study
Study date
2015
Authorising party
Public
Auth party contact address
-
Data no
276001
Author
Toth C
Title
Drug safety evaluation of pregabalin
Study date
2012
Authorising party
Public
Auth party contact address
-
Data no
275992
Author
Mann D et al
Title
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: A phase 1,
randomized controlled study
Study date
2014
Authorising party
Public
Auth party contact address
-
Data no
275977
Author
Chen W et al
Title
Preoperative Low-dose and High-dose Pregabalin and Cardiovascular Response to Endotracheal Intubation: A Prospective, Randomized, Single-blind, Controlled Study in China
Study date
2019
Authorising party
Public
Auth party contact address
-
Data no
275978
Author
Cohen SM et al
Title
Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance
Study date
2009
Authorising party
Public
Auth party contact address
-
Data no
275979
Author
Cook JC et al
Title
Fenretinide, Troglitazone, and Elmiron Add to Weight of Evidence Support for Hemangiosarcoma Mode-of-Action From Studies in Mice
Study date
2018
Authorising party
Public
Auth party contact address
-
Data no
275990
Author
Lockwood PA et al
Title
The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women
Study date
2016
Authorising party
Public
Auth party contact address
-
Date

Application Date

Application No

Application Number

144782
Product/Active constituent Name

Application Product Name

Pest Controllers Own Fipronil 100 SC Termiticide & Insecticide

Application details

Product name:

Pest Controllers Own Fipronil 100 SC Termiticide & Insecticide

Product number:

89141

Applicant Name:

AMGROW PTY LTD

Application purpose and description of use:

Variation of product registration and label approval to add additional uses.

Active constituents:

Active constituent name
58418 - FIPRONIL

Description of data provided:

Data no
274822
Author
Ian Ridley
Title
GLOBE24001 REPORT FINAL 24MAY24
Study date
24/05/2024
Authorising party
Applicant
Auth party contact address
UNIT B2A, 3/29 BIRNIE AVENUE LIDCOMBE Australia
Data no
274823
Author
Ian Ridley
Title
GLOBE24001 DATA GREEN-HEAD ANT
Study date
24/05/2024
Authorising party
Applicant
Auth party contact address
UNIT B2A, 3/29 BIRNIE AVENUE LIDCOMBE Australia
Data no
274824
Author
Ian Ridley
Title
GLOBE24001 DATA MEAT ANT
Study date
24/05/2024
Authorising party
Applicant
Auth party contact address
UNIT B2A, 3/29 BIRNIE AVENUE LIDCOMBE Australia
Data no
274825
Author
Ian Ridley
Title
GLOBE24001 DATA BLACK HOUSE ANT
Study date
24/05/2024
Authorising party
Applicant
Auth party contact address
UNIT B2A, 3/29 BIRNIE AVENUE LIDCOMBE Australia
Date

Application Date

Application No

Application Number

144862
Product/Active constituent Name

Application Product Name

FLUNIXIN MEGLUMINE

Application details

Product name:

FLUNIXIN MEGLUMINE

Active name:

FLUNIXIN MEGLUMINE

Applicant Name:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

Application purpose and description of use:

The purpose of this application is to seek approval of an existing active constituent, FLUNIXIN MEGLUMINE from a new source for use in veterinary chemical products.

Description of data provided:

Data no
275768
Author
Mohanraj VJ (Ed.)
Title
Part 2 Chemistry - Vol 1 of 1.pdf Size (bytes): 10662365
Study date
July 2024
Authorising party
Applicant
Auth party contact address
UNIT 7, 15-21 Butler Way TULLAMARINE Australia
Date

Application Date

Application No

Application Number

145029
Product/Active constituent Name

Application Product Name

Metacoxx KG Oral Suspension for Dogs

Application details

Product name:

Metacoxx KG Oral Suspension for Dogs

Product number:

87621

Applicant Name:

DECHRA VETERINARY PRODUCTS (AUSTRALIA) PTY. LTD.

Application purpose and description of use:

Variation of label approval to reword indication.

Active constituents:

Active constituent name
82924 - Meloxicam
Date

Application Date

Application No

Application Number

145122
Product/Active constituent Name

Application Product Name

EXIREL INSECTICIDE

Application details

Product name:

EXIREL INSECTICIDE

Product number:

64103

Applicant Name:

FMC AUSTRALASIA PTY LTD

Application purpose and description of use:

Variation of product registration to allow a larger pack size than is currently registered.

Active constituents:

Active constituent name
66659 - CYANTRANILIPROLE
Date

Application Date

Application No

Application Number

145157
Product/Active constituent Name

Application Product Name

GENFARM 2,4-D B SELECTIVE HERBICIDE

Application details

Product name:

GENFARM 2,4-D B SELECTIVE HERBICIDE

Product number:

88883

Applicant Name:

NUTRIEN AG SOLUTIONS LIMITED

Application purpose and description of use:

To vary the formulation.

Description of data provided:

Data no
277003
Author
NUFARM AUSTRALIA LIMITED
Title
Consent
Study date
19-Aug-2024
Authorising party
NUFARM AUSTRALIA LIMITED
Auth party contact address
-